Riskpilot← Back to searchSign inGet full accessFyskliniken i Linköping AB
ABActiveOrg 5567609069Jägarvallsvägen 48Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20081 employees
Revenue 2024
SEK 775K
+15% vs 2023
EBITDA margin
2.4%
+6731% vs 2023
Equity ratio
91.0%
Financial strength
Net profit 2024
SEK -1K
+92% vs 2023
| Revenue | SEK 775K | +15% |
| EBITDA | SEK 19K | +6731% |
| Net profit | SEK -1K | +92% |
| Total assets | SEK 242K | +1% |
| Equity | SEK 221K | -1% |
| Employees | 1 | — |
Legal name
Fyskliniken i Linköping AB
Org number
5567609069
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 juli 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva rehabilitering, träning, tester, utbildning, viktreducering samt försäljning av produkter med anknytning till denna verksamhet samt därmed förenlig verksamhet.
Address
Jägarvallsvägen 48
Phone
+46736642858
Email
lena@fyskliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 220 | 1 114 | 810 | 673 | 775 |
| Staff expenses | — | — | −328 | −280 | −479 |
| EBITDA | 47 | 58 | −51 | −0 | 19 |
| Depreciation & amort. | −23 | −24 | −14 | −17 | −20 |
| EBIT | 24 | 34 | −65 | −17 | −2 |
| Net financials | — | — | 0 | 1 | 1 |
| Profit before tax | 24 | 43 | −65 | −16 | −1 |
| Tax | −7 | −12 | −0 | — | — |
| Net profit | 17 | 31 | −65 | −16 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 387 | 339 | 298 | 240 | 242 |
| Equity | 272 | 303 | 238 | 222 | 221 |
| Long-term debt | 1 | 1 | 12 | 0 | — |
| Short-term debt | 104 | 35 | 48 | 18 | 22 |
| Total debt | 105 | 36 | 60 | 18 | 22 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20202024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
3.20×
This company
1.12×
Market median
+186% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fyskliniken i Linköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Rydqvist | Chief Executive Officer | 0 companies |
| Carl Emil Ekdahl | Deputy Board Member | 0 companies |
| Emmie Linnea Ekdahl | Deputy Board Member | 0 companies |